NC Court Sides With Merck in Class Action Gardasil Vaccine Injury Lawsuit
The District Court in North Carolina sided with Merck & Co. and granted a summary judgment motion to dismiss plaintiff’s failure to warn claims in ongoing litigation between the pharmaceutical giant and young women injured by the Gardasil vaccine. The lawsuit alleged that Merck covered up the risks associated with the company’s blockbuster vaccine which […]
HHS Plans to Close FDA Loophole that Allows Food Companies to “Self-Affirm” Safety of Ingredients
On Mar. 10, 2025, U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. ordered the U.S. Food and Drug Administration (FDA) to revise a long-exploited loophole that allows food companies to “self-affirm” that their ingredients are safe.1 2 The FDA’s Generally Recognized as Safe, or GRAS, food designation was created by Congress in […]
Glenmark Pharmaceuticals Recalls 1.5 Million Bottles of Generic ADHD Drug
Glenmark Pharmaceuticals, Inc., a subsidiary of Glenmark Pharmaceuticals Ltd. of Mumbai, India, is recalling 1.476 million bottles of a generic Attention Deficit Hyperactivity Disorder (ADHD) medication called atomoxetine from the U.S market, according to the U.S. Food and Drug Administration (FDA).1 Eli Lilly had once marketed the branded version of the drug, Strattera, but stopped […]
COVID Antiviral Paxlovid Provides “No Significant Benefit” to Vaccinated Seniors
Paxlovid, the antiviral drug that became the go-to treatment for SARS-CoV-2 infections during the pandemic, did not reduce hospitalizations or death in older adults who had gotten COVID-19 shots, according to a new study published in the Journal of the American Medical Association (JAMA) last month. Researchers who tested the COVID treatment Paxlovid (nirmatrelvir-ritonavir) on […]
FDA Official Leaves Agency Through the “Revolving Door” and Returns to Pfizer
On Feb. 24,2025, Pfizer, Inc. announced that FDA official Patrizia Cavazzoni, MD will rejoin the pharmaceutical company, which makes and sells federally recommended vaccines and drugs, as Pfizer’s Chief Medical Officer and Executive Vice President. Most recently, Dr. Cavazzoni served as Director of the Center for Drug Evaluation and Research (CDER) at the U.S. Food […]
FDA Approves GSK’s 5-in-1 Meningococcal Vaccine
On Feb. 14, 2025, British pharmaceutical and biotechnology company GSK plc announced that the U.S. Food and Drug Administration (FDA) approved its 5-in-1 meningococcal vaccine PENMENVY for licensure and use in individuals aged 10 through 25 years. The vaccine targets five major serogroups of the bacterium Neisseria meningitidis (A, B, C, W, and Y), which […]